Midazolam-Baxter midazolam (as hydrochloride) 5mg/1 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025

Midazolam-Baxter midazolam (as hydrochloride) 5mg/5 mL

Availability: Unavailable Deletion from market: 31 May 2025

APO-BETAHISTINE betahistine dihydrochloride 16 mg

Availability: Unavailable Deletion from market: 06 Aug 2024

KETOROLAC-BAXTER ketorolac trometamol 30 mg/1 mL

Availability: Unavailable Deletion from market: 01 Sep 2025

BROOKLYNN drospirenone/ethinyloestradiol 3 mg/30 microgram

Availability: Unavailable Deletion from market: 19 Mar 2025

BROOKE drospirenone/ethinyloestradiol 3 mg/20 microgram

Availability: Unavailable Deletion from market: 19 Mar 2025

CLINDAMYCIN BNM clindamycin (as hydrochloride) 150 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Aug 2024

NortriTABS nortriptyline (as hydrochloride) 25 mg

Availability: Unavailable Deletion from market: 31 Dec 2024

NortriTABS nortriptyline (as hydrochloride) 10 mg

Availability: Unavailable Deletion from market: 31 Dec 2024

CISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg

Availability: Unavailable Deletion from market: 10 Dec 2024

CISATRACURIUM ACCORD cisatracurium (as besilate) 150 mg

Availability: Unavailable Deletion from market: 19 Sep 2024

PETIBELLE ethinylestradiol 30 microgram

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jul 2025